HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Matsuoka Selected Research

Protein Kinase C

7/2009Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.
1/2007The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Matsuoka Research Topics

Disease

40Neoplasms (Cancer)
02/2024 - 11/2002
24Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 08/2004
12Neoplasm Metastasis (Metastasis)
02/2024 - 01/2007
8Infections
09/2023 - 11/2002
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2019 - 01/2015
7Lymphoma (Lymphomas)
10/2023 - 12/2016
7Rectal Neoplasms (Rectal Cancer)
12/2020 - 11/2002
6Stroke (Strokes)
01/2022 - 01/2015
6Thrombosis (Thrombus)
06/2019 - 01/2010
5Hemorrhage
05/2023 - 10/2017
5Leukemia
02/2023 - 01/2011
4Graft vs Host Disease (Graft-Versus-Host Disease)
05/2023 - 06/2011
4Neutropenia
09/2022 - 10/2013
4Peripheral Nervous System Diseases (PNS Diseases)
08/2022 - 10/2013
3Stomach Neoplasms (Stomach Cancer)
02/2024 - 02/2022
3Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2024 - 02/2013
3Atherosclerosis
01/2023 - 04/2020
3COVID-19
01/2023 - 01/2022
3Disease Progression
11/2021 - 10/2013
3Anemia
12/2020 - 03/2019
3B-Cell Lymphoma (Lymphoma, B Cell)
07/2019 - 10/2008
3Colonic Neoplasms (Colon Cancer)
01/2019 - 02/2014
3Acute Coronary Syndrome
01/2019 - 08/2016
3Hematologic Neoplasms (Hematological Malignancy)
10/2018 - 08/2013
3Heart Failure
08/2018 - 02/2013
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2012 - 10/2008
3Melanoma (Melanoma, Malignant)
10/2009 - 01/2007
2Diarrhea
10/2023 - 03/2009
2Sepsis (Septicemia)
09/2023 - 08/2013
2Cardiovascular Diseases (Cardiovascular Disease)
02/2023 - 12/2014
2Ischemia
01/2023 - 01/2021
2Dyslipidemias (Dyslipidemia)
01/2023 - 04/2020
2Esophageal Squamous Cell Carcinoma
01/2023 - 04/2022
2Wounds and Injuries (Trauma)
08/2022 - 01/2020
2Myocardial Infarction
01/2022 - 06/2005
2Carcinogenesis
02/2021 - 01/2007
2Pathologic Constriction (Stenosis)
01/2021 - 08/2009
2Splenomegaly
12/2020 - 09/2019
2Hepatocellular Carcinoma (Hepatoma)
05/2020 - 04/2020
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2019 - 02/2013
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2019 - 04/2009
2Hypersensitivity (Allergy)
05/2017 - 01/2015
2Hypertension (High Blood Pressure)
08/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

8Fluorouracil (Carac)FDA LinkGeneric
09/2022 - 11/2002
6Bevacizumab (Avastin)FDA Link
12/2022 - 10/2013
6Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2022 - 10/2013
5Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2007
5Leucovorin (Folinic Acid)FDA Link
11/2021 - 11/2002
4CytokinesIBA
01/2023 - 01/2021
4Messenger RNA (mRNA)IBA
01/2022 - 01/2007
4CholesterolIBA
05/2020 - 01/2015
4XELOXIBA
05/2017 - 01/2015
3Indicators and Reagents (Reagents)IBA
11/2023 - 08/2004
3Gemtuzumab (Mylotarg)FDA Link
02/2023 - 11/2018
3Cisplatin (Platino)FDA LinkGeneric
01/2023 - 02/2022
3Rituximab (Mabthera)FDA Link
01/2023 - 04/2009
3EnzymesIBA
01/2023 - 05/2020
3trifluridine tipiracil drug combinationIBA
12/2022 - 01/2019
3ClaudinsIBA
07/2022 - 10/2017
3Hemoglobins (Hemoglobin)IBA
01/2022 - 01/2012
3Capecitabine (Xeloda)FDA Link
11/2021 - 01/2015
3Irinotecan (Camptosar)FDA LinkGeneric
11/2021 - 01/2018
3Voriconazole (Vfend)FDA LinkGeneric
11/2019 - 01/2011
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
02/2019 - 06/2011
3Peptides (Polypeptides)IBA
01/2018 - 07/2002
3Biomarkers (Surrogate Marker)IBA
02/2017 - 07/2013
3Monoclonal AntibodiesIBA
01/2017 - 07/2002
3SteroidsIBA
12/2016 - 03/2009
2Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
05/2023 - 04/2020
2LigandsIBA
01/2023 - 01/2023
2BNT162 VaccineIBA
10/2022 - 01/2022
2Immunoglobulin G (IgG)IBA
10/2022 - 05/2020
2regorafenibIBA
11/2021 - 02/2021
2BariumIBA
05/2021 - 06/2005
2Phosphotransferases (Kinase)IBA
02/2021 - 09/2019
2Small Interfering RNA (siRNA)IBA
05/2020 - 04/2020
2Immunoglobulins (Immunoglobulin)IBA
04/2020 - 09/2012
2AntigensIBA
09/2019 - 08/2004
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2019 - 01/2015
2TolvaptanFDA Link
02/2018 - 02/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2017 - 09/2010
2Sirolimus (Rapamycin)FDA Link
05/2017 - 08/2009

Therapy/Procedure

29Therapeutics
01/2023 - 11/2002
28Drug Therapy (Chemotherapy)
02/2024 - 11/2002
9Hematopoietic Stem Cell Transplantation
01/2024 - 06/2011
6Stents
01/2019 - 03/2005
5Chemoradiotherapy
12/2020 - 11/2009
3Catheters
09/2023 - 11/2002
3Lymph Node Excision (Lymph Node Dissection)
03/2020 - 11/2015
3Stem Cell Transplantation
03/2019 - 02/2013
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2019 - 01/2015
3Percutaneous Coronary Intervention
01/2019 - 10/2017
2Transplantation
01/2023 - 02/2019
2Operative Time
08/2022 - 02/2021
2Colectomy
04/2022 - 02/2014
2Hepatectomy
02/2019 - 03/2018
2Aftercare (After-Treatment)
02/2019 - 12/2015
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2019 - 02/2013
2Adjuvant Chemotherapy
05/2017 - 10/2004
2Neoadjuvant Therapy
01/2017 - 04/2013